Newsroom | 58241 results

LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz reminds investors of the upcoming October 5, 2026 deadline to participate as a lead plaintiff in the securities fraud class action lawsuit filed on behalf of investors who acquired Replimune Group, Inc. (“Replimune” or the “Company”) (NASDAQ: REPL) securities between October 20, 2025 and April 10, 2026, inclusive (the “Class Period”). IF YOU ARE AN INVESTOR WHO LOST MONEY ON REPLIMUNE GROUP, INC. INVESTMENTS, CLICK HERE TO PARTICIPA...

BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith reminds investors of the upcoming October 5, 2026 deadline to file a lead plaintiff motion in the case filed on behalf of investors who purchased Replimune Group, Inc. (“Replimune” or the “Company”) (NASDAQ: REPL) securities between October 20, 2025 and April 10, 2026, inclusive (the “Class Period”). IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN REPLIMUNE GROUP, INC. (REPL), CONTACT THE LAW OFFICES OF HOWARD G. SMITH TO PARTICIPATE...

LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay Wolke & Rotter LLP reminds investors of the upcoming October 5, 2026 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Replimune Group, Inc. (“Replimune” or the “Company”) (NASDAQ: REPL) securities between October 20, 2025 and April 10, 2026 inclusive (the “Class Period”). IF YOU SUFFERED A LOSS ON YOUR REPLIMUNE GROUP, INC. INVESTMENTS, CLICK HERE TO INQUIRE ABOUT POTENT...

NEW YORK--(BUSINESS WIRE)--Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of ADMA Biologics, Inc. (NASDAQ: ADMA) between August 9, 2024 and March 25, 2026, both dates inclusive (the “Class Period”), of the important August 10, 2026 lead plaintiff deadline in the securities class action first filed by the Firm. So what: If you purchased ADMA Biologics securities during the Class Period you may be entitled to compensation without payment of any out of poc...

LINCOLN, Neb.--(BUSINESS WIRE)--Continuing the firm’s strategic investment in talent and national growth, Hilgers PLLC has promoted Kelsey Shofner, Scott Scheinberg and Will Burgess to partner. The promotions strengthen the firm's leadership in its corporate, litigation and discovery practices and reflect Hilgers' continued expansion in key markets across the country. "As Hilgers continues to grow, we're intentional about investing in leaders who have earned the trust of our clients and colleag...

LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz announces an investigation of UWM Holdings Corporation (“UWM” or the “Company”) (NYSE: UWMC) on behalf of investors concerning the Company’s possible violations of federal securities laws. IF YOU ARE AN INVESTOR WHO LOST MONEY ON UWM HOLDINGS CORPORATION (UWMC), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING A CLAIM TO RECOVER YOUR LOSS. What Is The Investigation About? On August 6, 2026, UWM Holdings reported a hedge established...

NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Bowhead Specialty Holdings Inc. (NYSE: BOW) to American Family Mutual Insurance Company, S.I. Under the terms of the proposed transaction, shareholders of Bowhead will receive $34.00 in cash for each share of Bowhead that they own. KSF is seeking to determine whether this consideration and the proce...

NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Supernus Pharmaceuticals, Inc. (NasdaqGM: SUPN) to Indivior Pharmaceuticals, Inc. (Nasdaq: INDV). Under the terms of the proposed transaction, shareholders of Supernus will receive 1.5401 common shares of Indivior for each share of Supernus that they own. KSF is seeking to determine whether this con...

NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Integer Holdings Corporation (NYSE: ITGR) to KKR. Under the terms of the proposed transaction, shareholders of Integer will receive $127.00 in cash for each share of Integer that they own. KSF is seeking to determine whether this consideration and the process that led to it are adequate, or whether...

NEW YORK CITY & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Atkore Inc. (NYSE: ATKR) to Prysmian S.p.A. Under the terms of the proposed transaction, shareholders of Atkore will receive $95.00 in cash for each share of Atkore that they own. KSF is seeking to determine whether this consideration and the process that led to it are adequate, or whether the...